One other plausible explanation for the differences between the in vivo situation and isolate lysosomes could be that only the CMA of specific substrates is accelerated in the lupus context and that substrates such as Tau or GAPDH are not among those. The gene discussed is GAPDH; the disease is systemic lupus erythematosus.